Clinical progress on nanoparticle albumin - bound paclitaxel
XIE Li-li
YANG Tong-jiang
ZHANG Cui-ping
SHAN Yan-qiang
Abstract：Nanoparticle albumin - bound paclitaxel(NAB - P)is targeted form of paclitaxel,it has demonstrated clinical benefit in metastatic breast cancer,NSCLC,adenocarcinoma of the pancreas and so on. The advancement of NAB - P in cur-rent clinic researches were reviewed in this article.
Keywords：PaclitaxelAlbumin - boundAnticancerClinical progress
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 289-291 )